Minimally Invasive Surgeries, Innovation Of New Technologies & Therapies, Growing Cases By Spinal Cord Stimulation 2016 Edition

"Global Spinal Cord Stimulation Market Report: 2016 Edition" The Report covers current Market Trends, Worldwide Analysis, Global Forecast, Review, Share, Size, Growth, Effect.

Description-

Chronic pain is an unpleasant sense of discomfort that persists or progresses over a long period of time. A chronic back pain can be treated through spinal cord stimulation (SCS) therapy. It is a process that uses soft thin wires with electrical leads to be placed in the spinal column through needle so as to cure chronic back pain. This process doesn’t eliminate the pain; it just interferes with the signals sent to the brain. The SCS surgery is performed in two stages: trial stimulation and permanent implantation.

Get Sample Report With TOC @ https://goo.gl/3bGHdX

Spinal cord stimulation therapy is used to reduce the pain signals that are sent to the brain through spinal cord which in return release pain relief chemicals. For this process, a spinal cord stimulator also known as dorsal column stimulator, is surgically placed under the skin to send a mild electrical current to the spinal cord. The process has its advantages and disadvantages.

The spinal cord stimulation (SCS) market is vast and remains relatively untouched with huge potential to treat widespread chronic back pain. The global SCS market is expected to increase in the coming years. The US has the chronic back pain prevalence with maximum number of addressable population and system implants.

The key factors driving the growth in the SCS market includes increasing adult population in the US, increasing demand for minimally invasive surgeries, innovation of new technologies & therapies, growing cases of obesity, and rise in ageing demographics. However, there are number of factors which are hindering the growth of the SCS market like high cost associated with therapy, tough regulatory approvals, and major reliance on traditional SCS therapy.

Table of Content
1. Market Overview
1.1 Introduction    
1.2 Electrical Stimulation
1.3 Spinal Cord Stimulator    
1.4 Mechanism of SCS    
1.5 Treatment by SCS    
1.6 Advantages & Disadvantages    
1.7 Risks Associated
2. Global Market
2.1 Global SCS Market by Value    
2.2 Global SCS Market by Region    
2.3 Global SCS Addressable Population    
2.4 Global SCS System Implants Volume
3. Regional Markets
3.1 The US    
3.1.1 The US Chronic Back Pain Prevalence    
3.1.2 The US Addressable SCS Population    
3.1.3 The US SCS Implant Systems Volume    
3.1.4 The US SCS Treatment by Indication    
3.1.5 The US SCS Market by Value
3.2 Outside the US    
3.2.1 Addressable SCS Population outside the US    
3.2.2 SCS Implant Systems Volume outside the US    
3.2.3 Rechargeable SCS Market Value outside the US    
3.2.4 SCS Market Value outside the US
4. Market Dynamics
4.1 Growth Drivers
4.1.1 Increasing Adult Population in the US    
4.1.2 Increasing Demand for Minimally Invasive Surgeries    
4.1.3 Innovation of New Technologies & Therapies    
4.1.4 Rising Global Healthcare Expenditure    
4.1.5 Growing Cases of Obesity    
4.1.6 Rise in Ageing Demographics
4.2 Trends
4.2.1 Aspects of Choosing SCS Devices in the US
4.2.2 Increasing Trial Units for SCS Placements in the US    
4.2.3 Advancements in Spine Therapies    
4.2.4 Rising Mergers & Acquisitions in SCS Market

ResearchMoz is the world’s fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz’s service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Researchmoz Global Pvt. Ltd.
90 State Street,
Albany, NY 12207,
United States,
Tel: 866-997-4948 (Us-Canada Toll Free),
Tel: +1-518-621-2074

This release was published on openPR.